Company Data

Verona Pharma plc

Ticker
VRNA
Current Price
$67.96 5.87%
Market Cap
$5.6B
Price Target
Refer to Report
Volume
2.1M
52wk Range
$11.39 - $65.5
Advanced Market Data

Overview

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy